Skip to main content
SpringerLink
Log in

Transcatheter Arterial Chemoembolization (TACE) with Lipiodol to Treat Hepatocellular Carcinoma: Survey Results from the TACE Study Group of Japan

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

The purpose of this study was to retrospectively clarify the current status in Japan of TACE using Lipiodol together with anticancer agents to treat hepatocellular carcinoma (HCC). We retrospectively surveyed 4,659 (average annual total) procedures for HCC over the years 2002–2004 at 17 institutions included in the TACE Study Group of Japan. The survey included six questions that were related mainly to TACE and Lipiodol for HCC treatment. The most frequently applied among the 4,659 procedures at the 17 institutions were TACE (2,310; 50%) and local ablation (1,395; 30%). Five of the institutions applied 201–300 procedures and 4 applied 101–200. Lipiodol was used in “all procedures” and in “90% or more” at seven and nine institutions, respectively. Almost all institutions applied 4–6 (mean, 5) ml of Lipiodol during TACE to treat tumors 5 cm in diameter. In conclusion, this survey clarified that TACE using Lipiodol and anticancer agents is a popular option for HCC treatment in Japan.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. EI-Serag HB (2002) Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 35(Suppl):72–78

    Article  Google Scholar 

  2. Brown BD, Geschwind JF, Soulen MC, et al. (2006) Society of interventional radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol 17:217–223

    Article  PubMed  Google Scholar 

  3. Kanematsu T, Inokuchi K, Sugimachi K, et al. (1984) Selective effects of lipiodolized antitumor agents. J Surg Oncol 25:218–226

    Article  PubMed  CAS  Google Scholar 

  4. Ohishi H, Uchida H, Yoshimura H, et al. (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154:25–29

    PubMed  CAS  Google Scholar 

  5. Sasaki Y, Imaoka S, Kasugai H, et al. (1987) A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 60:1194–1203

    Article  PubMed  CAS  Google Scholar 

  6. Ohishi H, Yoshimura H, Uchida H, et al. (1989) Transcatheter arterial embolization using iodized oil (Lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 23(Suppl):S33–S36

    Article  PubMed  Google Scholar 

  7. Nakamura H, Hashimoto T, Oi H, et al. (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170:783–786

    PubMed  CAS  Google Scholar 

  8. Konno T (1990) Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium. Cancer 66:1897–1903

    Article  PubMed  CAS  Google Scholar 

  9. Uchida H, Ohishi H, Matsuo N, et al. (1990) Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and gelfoam particle for hepatocellular carcinoma. CardioVasc Interv Radiol 13:140–145

    Article  CAS  Google Scholar 

  10. Uchida H, Matsuo N, Sakaguchi H, et al. (1993) Segmental embolotherapy for hepatic cancer: key to success. CardioVasc Interv Radiol 16:67–71

    Article  CAS  Google Scholar 

  11. Uchida H, Matsuo N, Nishimine K, et al. (1993) Transcatheter arterial embolization for hepatoma with Lipiodol. Hepatic arterial and segmental use. Semin Interv Radiol 10:19–26

    Article  Google Scholar 

  12. Matsuo N, Uchida H, Nishimine K, et al. (1993) Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue. J Vasc Interv Radiol 4:543–549

    Article  PubMed  CAS  Google Scholar 

  13. Matsui O, Kadoya Y, Yoshikawa J, et al. (1993) Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188:79–83

    PubMed  CAS  Google Scholar 

  14. Nishimine K, Uchida H, Matsuo N, et al. (1994) Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 33(Suppl):S60–S68

    Article  PubMed  Google Scholar 

  15. Nakao N, Uchida H, Kamino K, et al. (1994) Determination of the optimum dose level of Lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis. CardioVasc Interv Radiol 17:76–80

    Article  CAS  Google Scholar 

  16. Sakaguchi H, Uchida H, Maeda, et al. (1995) Combined transjugular intrahepatic portosystemic shunt and segmental Lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report. CardioVasc Interv Radiol 18:9–15

  17. Matsuo N, Uchida H, Sakaguchi H, et al. (1997) Optimal lipiodol volume intracatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on Lipiodol accumulation pattern and histopathological findings. Semin Oncol 24(Suppl 6):61–70

    Google Scholar 

  18. Ueno K, Miyazono N, Inoue H, et al. (2000) transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 88:574–1581

    Article  Google Scholar 

  19. Takayasu K, Muramatsu Y, Maeda T, et al. (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR 176:681–688

    PubMed  CAS  Google Scholar 

  20. Higashihara H, Okazaki M (2002) Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience. Hepatogastroenterology 49:72–78

    PubMed  Google Scholar 

  21. Yamakado K, Nakatsuka A, Ohmori S, et al. (2002) Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 13:1225–1232

    Article  PubMed  Google Scholar 

  22. Iwamoto S, Sanafuji H, Okuda K (2003) Angiographic subsegmentectomy for the treatment of patients with small hepatocellular carcinoma. Cancer 97:1051–1056

    Article  PubMed  Google Scholar 

  23. Miyayama S, Matsui O, Taki K, et al. (2004) Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery: anatomical and technical analysis. J Vasc Interv Radiol 15:815–823

    PubMed  Google Scholar 

  24. Bronowicki JP, Vetter D, Dumas F, et al. (1994) Transcatheter oily chemoembolization for hepatocellular carcinoma: a 4-year study of 127 French patients. Cancer 74:16–24

    Article  PubMed  CAS  Google Scholar 

  25. Groupe d’Etude et de Traitment du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261

    Article  Google Scholar 

  26. Pelletier G, Ducreux M, Gay F, et al. (1998) Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. J Hepatol 27:129–134

    Article  Google Scholar 

  27. Bruix J, Llovet JM, Castells A, et al. (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578–1583

    Article  PubMed  CAS  Google Scholar 

  28. Solomon B, Soulen MC, Baum RA, et al. (1999) Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population. J. Vasc Interv Radiol 10:793–798

    Article  PubMed  CAS  Google Scholar 

  29. Treviasani F, De Notariis S, Rossi C, et al. (2001) Randomized control trials on chemoembolization for hepatocellular carcinoma: Is there room for new studies? J Clin Gastroenterol 32:383–389

    Article  Google Scholar 

  30. Lo CM, Ngan H, Tso WK, et al. (2002) Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171

    Article  PubMed  CAS  Google Scholar 

  31. Llovet JM, Real MI, Montana X, et al. (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma. Lancet 359:1734–1739

    Article  PubMed  Google Scholar 

  32. Barone M, Ettorre GC, Ladisa R, et al. (2002) Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma. Hepatogastroenterology 50:183–187

    Google Scholar 

  33. Chen MS, Li JQ, Zhang YQ, et al. (2002) High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 8:74–78

    PubMed  Google Scholar 

  34. Saccheri S, Lovaria A, Sangiovanni A, et al. (2002) Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinoma. J Vasc Interv Radiol 13:995–999

    Article  PubMed  Google Scholar 

  35. Geshwind JF, Ramsely DE, Choti MA, et al. (2003) Chemoembolization of hepatocellular carcinoma: results of a meta-analysis. Am J Clin Oncol 26:344–349

    Google Scholar 

  36. Eurvilaichit C (2004) Outcome of transcatheter oily arterial chemoembolization in patients with hepatocellular carcinoma. Hepatogastroenterology 51:20–24

    PubMed  Google Scholar 

  37. Bonneman B (2006) Lipiodol—mechanism of action for chemoembolization. Jpn IVR 21:64–68

    Google Scholar 

  38. Takayasu K, Arii S, Ikai I, et al. (2006 ) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461–469

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We express our sincere appreciation to the following institutions for their valuable contributions to this study (Asahikawa-Kosei General Hospital, Mitsui Memorial Hospital, National Cancer Center Hospital, Niigata University, Kanazawa University, Aichi Cancer Center, Gifu University, Wakayama Medical College, Nara Medical University, Osaka University, Osaka Red Cross Hospital, Ogaki Municipal Central Hospital, Hyogo College of Medicine, Fukuoka University, Kagoshima University).

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

    Mituo Satake & Yasuaki Arai

  2. IVR Center and Department of Radiology, Daiyukai General Hospital, 1-9-9 Sakura, Ichinomiya-shi, Aichi, 491-0036, Japan

    Hideo Uchida, Takashi Nagata & Tomohiko Yamane

  3. Department of Radiology, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8522, Japan

    Hiroshi Anai, Hirosi Sakaguchi & Kimihiko Kichikawa

  4. Department of Gastroenterology, Osaka Red Cross Hospital, 5-30 Fudegasaki-cho, Tennoji-ku, Osaka, 543-8555, Japan

    Yukio Osaki

  5. Department of Radiology, School of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuokashi, Fukuoka, 814-0180, Japan

    Masatoshi Okazaki & Hideyuki Higashihara

  6. Department of Radiology, Osaka University School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan

    Hironobu Nakamura & Keigo Osuga

  7. Department of Radiology, Hyogo College of Medicine, Mukogwa-cho, Nishinomiya-shi, Hyogo, 663-8501, Japan

    Norio Nakao & Shouzou Hirota

Authors
  1. Mituo Satake
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideo Uchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuaki Arai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Anai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hirosi Sakaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takashi Nagata
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tomohiko Yamane
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kimihiko Kichikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yukio Osaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masatoshi Okazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hideyuki Higashihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hironobu Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Keigo Osuga
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Norio Nakao
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Shouzou Hirota
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideo Uchida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Satake, M., Uchida, H., Arai, Y. et al. Transcatheter Arterial Chemoembolization (TACE) with Lipiodol to Treat Hepatocellular Carcinoma: Survey Results from the TACE Study Group of Japan. Cardiovasc Intervent Radiol 31, 756–761 (2008). https://doi.org/10.1007/s00270-007-9255-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-007-9255-7

Keywords

Search

Navigation